Informations techniques
Exploitant
Laboratoires PROSTRAKAN PHARMA
Présentation
DROLEPTAN 2,5 mg/ 1ml, solution injectable (IV) B/10 - CIP 561 122-8
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
w6MFrr7KnX97zAac